Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel and Albendazole for Neurocysticercosis
NCT00441285Phase 3Completed
- Sponsor
- Universidad Peruana Cayetano Heredia
- Start
- Jan 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of praziquantel in neurocysticercosis (NCC), sponsored by Universidad Peruana Cayetano Heredia. Started Jan 2010; status: completed.
02
Drugs
praziquantel
03
Conditions
neurocysticercosis (NCC)
Beyond the preview
Go deeper on NCT00441285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441285.